Skip to main content
Equibles
TSNDF logo

TSNDF · TerrAscend Corp. · Metrics

Track TSNDF — free

Use TSNDF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TSNDF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.51 -0.01 (-0.97%) At close · Oct 5
Rebalance outlook locked
Market Cap
$199.11M
Shares
309.18M
Volume · Oct 5 695.79K Avg daily vol (3M) 255.63K

TSNDF metrics

75 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.51
Market cap
$199.11M

Price action

20 metrics
Price change (1W)
-19.5%
Price change (30D)
-23.4%
Price change (3M)
-17.8%
Price change (6M)
-22.7%
Price change (YTD)
-28.1%
Price change (1Y)
-41.6%
Trailing year
Price change (5Y)
-92.8%
52-week high
$1.32
52-week low
$0.38
Change from 52-week high
-60.8%
Change from 52-week low
+36.3%
Annualized volatility
158.8%
Annualized volatility (3M)
84.6%
Beta
1.6
RSI (14D)
35.8
Price vs SMA 50
-13.1%
Price vs SMA 200
-21.7%
Avg volume (3M)
248,749
Relative volume
1.5
Average dollar volume
$144,531

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
309.18M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.8×
reciprocal yield 132.5%
P / book
2.4
reciprocal yield 42.2%
FCF yield
9.7%
TTM · current market cap
Buyback yield
0.2%
P / FCF
10.3
reciprocal yield 9.7%
P / operating cash flow
7.7
reciprocal yield 12.9%
Earnings yield
-18.6%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.6×
reciprocal yield 64.4%
EV / revenue historical average (5Y)
1.7×
reciprocal yield 60.4%
EV / EBIT historical average (3Y)
11.1×
reciprocal yield 9.0%
EV / EBIT historical average (5Y)
11.1×
reciprocal yield 9.0%
EV / EBITDA historical average (3Y)
9.4×
reciprocal yield 10.6%
EV / EBITDA historical average (5Y)
9.4×
reciprocal yield 10.6%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.2%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
52.8%
Operating margin
16.1%
Trailing 12 months
Net margin
-14.0%
Gross profit (TTM)
$139.26M
Operating profit (TTM)
$42.44M
Net income (TTM)
−$37.01M
Trailing 12 months
Diluted EPS (TTM)
$-0.13
FCF margin
7.3%
Effective tax rate
801.6%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.32

Growth

11 metrics
Revenue growth YoY
+3.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$263.91M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.4%
Year over year · more shares
Revenue CAGR (3Y)
+1.7%
Revenue CAGR (5Y)
+14.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-44.0%
Return on assets
-6.7%
Debt / equity
—
Current ratio
1.8
EBITDA (TTM)
$48.12M
Free cash flow (TTM)
$19.30M
Quick ratio
1.2
Interest coverage
1.4
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$42.03M
Total assets
$553.71M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$25.77M
Capital expenditures (TTM)
$6.47M
R&D (TTM)
—
SG&A (TTM)
$115.19M
Stock compensation (TTM)
$4.43M
R&D / revenue
—
Stock compensation / revenue
1.7%

Ownership (13F)

3 metrics
13F filers
1
13F filer change QoQ
+1
Institutional ownership
0.0%

Short interest

3 metrics
Short interest
0.3%
Latest settlement · 3.1 days to cover
Days to cover
3.1d
Short-squeeze score
34 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1778129 CUSIP 88105E108 Visit website Investor relations